Track topics on Twitter Track topics that are important to you
Qiagen and Freenome will collaborate on the development of next-generation sequencing-based companion diagnostics for immuno- -More-
Freenome, a leading artificial intelligence (AI) genomics company, announced the creation of its IMPACT Advisory Board, a group tasked with helping Freenome’s leadership ...
Introduces pipeline to reach patients more quickly with next-generation sequencing for cancer, in line with modernized regulatory approach from the U.S. Food and Drug...
South San Francisco–based Freenome, the leading artificial intelligence (AI) genomics company, is presenting promising early data on its efforts to utilize machine learning to d...
Freenome and the Medical University of Graz jointly announced the launch of a new Christian Doppler (CD) Laboratory dedicated to advancing research into early-cancer detect...
Freenome is using a type of artificial intelligence, called machine learning, to identify patterns of cell-free biomarkers in blood to detect cancer early. The purpose of this study is to ...
Headquartered in South San Francisco, Freenome is a health technology company developing accurate, accessible and non-invasive disease screening products for proactively treating ...
Freenome is an AI genomics company on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent their diseases. By applying advanced machine ...
We have published hundreds of Freenome, Inc. news stories on BioPortfolio along with dozens of Freenome, Inc. Clinical Trials and PubMed Articles about Freenome, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Freenome, Inc. Companies in our database. You can also find out about relevant Freenome, Inc. Drugs and Medications on this site too.
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...